The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nine-weeks versus one-year trastuzumab for early-stage HER2+ breast cancer: 10-year update of the Short-HER phase III randomized trial.
 
Pier Franco Conte
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Gilead Sciences; Reveal Genomics
Speakers' Bureau - AstraZeneca; BMS; Lilly; Novartis; Roche/Genentech
Research Funding - Merck KGaA (Inst)
Patents, Royalties, Other Intellectual Property - HER2Dx patent
Expert Testimony - AstraZeneca
 
Giancarlo Bisagni
No Relationships to Disclose
 
Federico Piacentini
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; GENTILI; Lilly; Novartis
 
Samanta Sarti
No Relationships to Disclose
 
Santino Minichillo
No Relationships to Disclose
 
Elisa Anselmi
No Relationships to Disclose
 
Michele Aieta
No Relationships to Disclose
 
Vittorio Gebbia
No Relationships to Disclose
 
A Schirone
Consulting or Advisory Role - Lilly; Novartis; Pfizer
Speakers' Bureau - Lilly; Novartis; Pfizer
 
Antonino Musolino
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai Europe; Lilly; Seagen
Research Funding - Lilly; Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Ornelia Garrone
Honoraria - Eisai; Lilly; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; EISAI; Gilead Sciences; MSD; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Ipsen
 
A Beano
No Relationships to Disclose
 
Anita Rimanti
No Relationships to Disclose
 
Francesco Giotta
No Relationships to Disclose
 
Anna Turletti
Travel, Accommodations, Expenses - Novartis; Roche
 
Maria Vittoria Dieci
Consulting or Advisory Role - Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Patents, Royalties, Other Intellectual Property - Patent pending HER2DX licensed to University of Padova
 
Roberto Vicini
No Relationships to Disclose
 
Sara Balduzzi
No Relationships to Disclose
 
R D'Amico
No Relationships to Disclose
 
Valentina Guarneri
Consulting or Advisory Role - Eisai; Exact Sciences; Gilead Sciences; Lilly; Merck Serono; MSD; Novartis; Olema Oncology
Speakers' Bureau - Amgen; AstraZeneca; GlaxoSmithKline; Lilly; Novartis
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Roche (Inst); Synthon (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Gilead/Forty Seven